Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
How optimistic are you for revenue growth in 2013?
More than last year 31%

Same as last year

33%
Less than last year 36%

Talk to us:
jupton@advanstar.com

Advertise with us:
Dtaylor-higgins@advanstar.com

23 July, 2013
EU and US Move to Fortify Pharma Supply Chain
Several key measures to ensure pharmaceutical product quality in the United States and European Union are progressing — either with immediate implementation or further discussion slated for July 2013. Patricia Van Arnum reports ...Read more
Social Media’s Not So Scary… Now for Social Business
Pharma marketers may finally be conquering their fear of social media. But in order to do so, they have to be prepared to become a ‘social business’ and this is still a sticking point, writes Peter Houston ... Read more
European Companies Respond to Patent Cliff
As the patent cliff continues to haunt the pharma industry, some companies are resorting to desperate measures, writes Nathan Jessop ... Read more
Evaluating Risk-Based Specifics for Pharmaceuticals
Chris Burgess provides an approach to risk-based product and raw-material specifications that can be applied to the pharmaceutical industry ... Read more
PharmExec Releases New eBook: The Best of the Successful Product Manager's Handbook Volume II
In the second volume of this four-volume set from the pages of Pharmaceutical Executive,
learn to think outside the box to meet both timeless and newly emerging obstacles to success ... Read more

Products/Services Profiles
Sciformix
SciVigilance – Pharmacovigilance in a box
Scivigilance provides the powerful combination of streamlined processes, domain expertise and robust technology that integrates disparate data and enables the seamless flow, collection processing and analysis of data.  Scivigilance delivers significant time and cost savings, efficiency and compliance gains, all while delivering the highest quality outcomes. Read More
Also in this issue
Clinical Trials: Why the Rise in UK Participants?
Video: Behind the Pharm Exec Top 50
What Happened to Outsourcing in Asia?